Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2005
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/28/2005EP1082292B1 Control of pain with endogenous cannabinoids
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005CN1675357A Pramyxovirus vectors encoding antibody and utilization thereof
09/28/2005CN1675344A Oil or fat composition
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675223A C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675222A C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675217A Oxycodone-hydrochloride polymorhs
09/28/2005CN1675215A Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
09/28/2005CN1675213A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675211A 新的嘌呤衍生物 New purine derivatives
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same
09/28/2005CN1675205A Novel quinuclidine derivatives and their use
09/28/2005CN1675204A 2-heteroaryl carboxamides
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675194A Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675184A Caspase inhibitors and uses thereof
09/28/2005CN1675183A Acutumine and acutumine compound synthesis and use
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1675180A Indole, indazole, and benzazole derivative
09/28/2005CN1675177A Modafinil polymorphic forms
09/28/2005CN1675173A Muscarinic agonists
09/28/2005CN1675169A Derivatives of glycinergic R(+)-2-amino-3-hydroxypropanoic acid
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/28/2005CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
09/28/2005CN1674936A Treatment of MS with goat serum
09/28/2005CN1674934A Vaccine compositions containing amyloid beta1-6 antigen arrays
09/28/2005CN1674931A T cell receptor CDR3 sequences and methods for detection
09/28/2005CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
09/28/2005CN1674914A Female hormone-containing patch
09/28/2005CN1674907A Use of reboxetine for the treatment of hot flashes
09/28/2005CN1674903A Composition for transnasal absorption
09/28/2005CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1674894A Ether substituted imidazopyridines
09/28/2005CN1674890A Methods of treating benzodiazepine site (BZD-s) associated syndromes using 2' hydroxyflavonoids
09/28/2005CN1674889A Methods of predicting GABAa receptor efficacies for flavonoid compounds and uses therefor
09/28/2005CN1674884A Synergistic combination of an alpha-2-delta ligand and a PDEV inhibitor for use in the treatment of pain
09/28/2005CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
09/28/2005CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier
09/28/2005CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
09/28/2005CN1673212A Interconnected medicine precursor of gabapentin and pregabalin and its medicinal use
09/28/2005CN1673210A Optical isomer of phencynonate and its use in preparing medicine
09/28/2005CN1673209A Active metabolic product of phencynonate and its medicinal use
09/28/2005CN1672726A Life-prolonging Chinese medicine prepn of haw
09/28/2005CN1672722A Heart-nourishing and tranquilizing medicine and its prepn process
09/28/2005CN1672700A External use medicine for treating facial paralysis peripherica and its prepn
09/28/2005CN1672697A Headache treating Chinese medicine
09/28/2005CN1672693A Qutongdan pellet for relieving pain and its prepn
09/28/2005CN1672686A Dispersive asiaticoside tablet and its prepn process
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction
09/28/2005CN1220510C Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method
09/28/2005CN1220494C Qiyeshenan drop pill for curing insomnia etc.
09/28/2005CN1220451C 健康食品 Healthy Food
09/27/2005US6949655 Acyclic piperidine derivatives
09/27/2005US6949653 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
09/27/2005US6949650 Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949579 Central nervous system disorders; antidiabetic agents
09/27/2005US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/27/2005US6949560 Imidazo-substituted compounds as p38 kinase inhibitors
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949555 Use of organic compounds
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949552 Remedial agent for anxiety neurosis or depression and piperazine derivative
09/27/2005US6949549 substituted imidazolo[5,1-a]phthalazine derivatives which are ligands for GABAA receptors containing the alpha 5 subunit and are therefore useful in therapy where cognition enhancement is required.
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949542 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/27/2005US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
09/27/2005US6949537 LY294002 and analogs thereof comprising a reversibly quaternized amine; use of the pro-compounds for treatment of a condition associated with PI-3 kinase activity, including inflammatory disease, age-related macular degeneration, hypertension
09/27/2005US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one
09/27/2005US6949527 Muscle relaxation
09/27/2005US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP)
09/27/2005US6949354 Detection of nervous system modulators; obtain preferential nervous system tissue in vitro, culture, incubate with modulator, monitor and evaluate adjustment in cell activity
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949257 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/27/2005CA2093306C (1-h-indol-1-yl)-2-(amino)acetamides and related (1h-indol-1-yl)-(aminoalkyl)amides, intermediates and a process for their preparation and their use as medicaments
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
1 ... 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 ... 1833